Patients using Mounjaro and Wegovy may regain most of the weight lost after stopping the treatment.

More and more Romanians are resorting to injections for weight loss, such as Mounjaro and Wegovy, which are GLP-1 receptor agonists. A study conducted by the University of Cambridge suggests that patients can regain almost two-thirds of the lost weight within a year of stopping treatment.

Although a quarter of the lost weight can be maintained in the long term, researchers warn that if the regained weight is primarily fat, individuals could end up in a worse situation than before treatment. It is essential for doctors and patients to be aware of the risks of weight regain and to adopt healthy habits to maintain results. Future studies are needed to assess the long-term effects of these medications.